Supply Chain

PharmTech spoke with Gabriela Grasa Mannino, Senior Director, Advanced Supply Chain Solutions, US Pharmacopeia about the current state of the drug supply chain and what actions USP is taking to make supply more secure.

The standards organization’s annual drug shortages report finds drug shortages lasting longer and the number of discontinuations rising, but the number of shortages themselves have gone down.

Integrated CDMO networks streamline complex drug development across advanced modalities like ADCs.

Even the threat of Greenland-related tariffs rattled drug supply chains and uncovered industry vulnerabilities to instability.

US pharma tariffs in 2025 forced companies to invest billions in reshoring manufacturing, mitigating rising costs, supply chain strain, and R&D delays.

With pharmaceutical tariffs fundamentally impacting costs, global supply chains, and more, it’s important for industry professionals to understand the basics.

The 100% tariff on imported drugs will pressure pharma companies to build manufacturing sites in the US or face significant costs.

The yearly convention in New York City showcased new and emerging technologies and gave participating exhibitors a chance to unveil their strategies for the second half of the 2020s.

Sitting down with the PharmTech Group at INTERPHEX 2025, Nicole Hunter, head of Global WMArchitect at WMFTS, explains the industry initiative around single-use assembly components resulting from supply disruptions caused by the COVID-19 pandemic.

The Act is the European Union’s plan to avert drug shortages.

Challenges that can prevent sponsors realizing the full potential of managed access programs can be overcome by embracing a just-in-time manufacturing strategy.

Frontier Scientific Solutions has unveiled plans to use a $1.5 billion commitment from a major investor to create a global free trade zone gateway to facilitate the life sciences supply chain using Wilmington International Airport in North Carolina.

Manufacturers of five autologous or matched allogenic cell therapy products have selected TrakCel's IT platform, OCELLOS, to orchestrate the administration of these therapies, which are approved or expected to be approved in 2024.

Recent hurricanes in the US close Baxter plant, shining a spotlight on supply chain fragility again.

Contract organizations offer assistance when managing changes to material suppliers during a product’s lifecycle.

Greater collaboration and understanding are needed to ensure the correct grade of excipient is used in drug products.

Qualifying material suppliers is a crucial step in ensuring safe and effective drug products.

The US currently relies heavily on imports from China and other overseas nations for APIs needed to manufacture drug products of critical importance to US patients.

A new initiative will advance access to quality medicines and vaccines in Africa.

The final drug product relies on the quality and reliability of the raw materials used in its production.

The company is collaborating with the Access to Oncology Medicines Coalition to expand patient access to immuno-oncology therapy Opdivo.

The midterm report of the European Medicines Agencies Network Strategy finds that the network has strengthened and is on track to achieve its objectives.

WHO provides a look at the world’s health as the agency turns 75.

Regulators in the European Union have published the first version a list of critical medicines in the EU to avoid potential shortages.

Drug shortages across Europe are being exacerbated by increased demand, struggling supply chains, and manufacturer suspensions.